Cue Biopharma (CUE) Share-based Compensation (QoQ) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Cue Biopharma | 449.73 Mn | 422.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -60.21% |
| Sep 30, 2025 | 21.38% |
| Jun 30, 2025 | -5.61% |
| Mar 31, 2025 | -14.34% |
| Dec 31, 2024 | -1.33% |
| Sep 30, 2024 | -9.80% |
| Jun 30, 2024 | -9.82% |
| Mar 31, 2024 | -6.08% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | 1.77% |
| Jun 30, 2023 | 1.95% |
| Mar 31, 2023 | -5.40% |
| Dec 31, 2022 | 2.33% |
| Sep 30, 2022 | -10.61% |
| Jun 30, 2022 | -23.31% |
| Mar 31, 2022 | 1.22% |
| Dec 31, 2021 | -8.53% |
| Sep 30, 2021 | 13.95% |
| Jun 30, 2021 | 17.16% |
| Mar 31, 2021 | 6.76% |
| Dec 31, 2020 | -8.73% |
| Sep 30, 2020 | -0.95% |
| Jun 30, 2020 | -20.50% |
| Mar 31, 2020 | 59.07% |
| Dec 31, 2019 | 38.71% |
| Sep 30, 2019 | 8.93% |
| Jun 30, 2019 | -25.28% |
| Mar 31, 2019 | -12.07% |
| Dec 31, 2018 | -26.37% |
| Sep 30, 2018 | 114.20% |
| Jun 30, 2018 | 10.10% |
| Mar 31, 2018 | 49.54% |
| Dec 31, 2017 | 3.11% |
| Sep 30, 2017 | 6.22% |
| Jun 30, 2017 | 30.20% |